Postoperative considerations for retinal detachments following keratoprosthesis implantation

News
Article

Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery

A patient undergoes eye surgery. Image credit: ©st.kolesnikov – stock.adobe.com

The study reinforced the need for frequent intraocular pressure evaluation and comprehensive periodic retinal assessments. Image credit: ©st.kolesnikov – stock.adobe.com

Retinal detachment (RD) is a severe complication associated with implantation of the Boston Type 1 Keratoprosthesis (B1KPro) that can result in permanently decreased visual acuity in a substantial portion of eyes.

Researchers from Spain and Croatia evaluated the risk factors for development of early and late RDs after B1KPro surgery and found that the risk factors differed for both periods,1 according to first author Eva Calpe, PhD. She is from the Centro de Oftalmología Barraquer and the Institut Universitari Barraquer, Universitat Autònoma de Barcelona, both in Barcelona, Spain.

The investigators conducted a retrospective cohort study that included 94 eyes (90 patients) that received a B1KPro implantation at the Centro de Oftalmología Barraquer from June 2006 to July 2022. All study patients had a minimum 1-year follow-up.

Analysis findings

The investigators found that the incidence of RD after B1KPro implantation was 29% (27/94). The RDs developed in 21% of eyes during the first postoperative year and in 7% of eyes thereafter.

A finding that emerged in this study was that during the first year after B1KPro surgery, hypotony and pars plana vitrectomy (PPV) that occurred at any time were significant risk factors for early RD development. Cases with late RDs, ie, those developing after 1 year following the B1KPro surgery, seem to be correlated significantly with peripheral retinal changes that occurred a few days before the loss of visual acuity and RD diagnosis.

Their data showed that “hypotony was a significant risk factor for early development of an RD (16/19 = 84%; odds ratio [OR ]= 14.5, P < 0.0001), together with aphakia (16/20 = 80%; OR = 5.9, P = 0.004), intraocular lens (IOL) removal (4/8 = 50%; OR = 6.2, P = 0.03), previous choroidal detachment (CD) (7/20 = 35%; OR = 35.5, P = 0.001), and PPV (15/20 = 75%; OR = 6.6, P = 0.006).”

The development of RDs later than 1 year postoperatively was associated with peripheral retinal changes that were detected a few days before the visual loss and diagnosis of the RD (4/6 = 66%; OR = 65, P < 0.0001).

Dr Calpe and colleagues concluded, “Hypotony emerged as one of the main factors influencing early RD occurrence after B1KPro implantation. Additionally, previous CD, PPV, aphakia, and IOL removal should be considered to estimate the risk of postoperative RD development. In contrast, peripheral retinal changes occurring after B1KPro implantation seem to be significantly related to late RD occurrence. It is plausible to think that the risk factors for RD after B1KPro implantation differ during the short and long postoperative time periods. This study reinforces the need for frequent intraocular pressure evaluation and comprehensive periodic retinal assessment over time.”

Reference

Calpe E, Fernández-Engroba J, Julio G, et al. Risk factors for early and late retinal detachment after Boston Type I keratoprosthesis surgery. Graefes Arch Clin Ophthalmol. 2024;

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
© 2025 MJH Life Sciences

All rights reserved.